Title

Prospective surveillance of D- recipients of D+ apheresis platelets: alloimmunization against D is not detected

UMMS Affiliation

Department of Medicine, Division of Transfusion Medicine

Date

6-1-2015

Document Type

Article

Medical Subject Headings

Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Humans; Isoantibodies; Male; Middle Aged; *Plateletpheresis; *Population Surveillance; Prospective Studies; Rh Isoimmunization; Rh-Hr Blood-Group System; Young Adult

Disciplines

Hematology | Hemic and Immune Systems | Hemic and Lymphatic Diseases

Abstract

BACKGROUND: Recent retrospective studies indicate that D- recipients of D+ apheresis platelets (PLTs) are not alloimmunized to D. Our hospital policy is to offer RhIG to D- women of childbearing age who received D+ apheresis PLTs but not to other D- recipients of D+ apheresis PLTs. We instituted prospective surveillance of the D- recipients who were not given RhIG.

STUDY DESIGN AND METHODS: All apheresis PLT recipients were prospectively entered into a database that recorded the patient's age, sex, diagnosis, D status, apheresis PLT transfusions, and antibody screen results from before and after PLT transfusions. Data are reported for PLTs transfused between October 16, 2012, and April 16, 2014, and antibody screens obtained through June 16, 2014. The analysis excludes neonates; women not more than 50 years of age; and patients who also received D+ red blood cells, received only D- PLTs, received RhIG, were previously alloimmunized to D, and did not have a follow-up antibody screen after the first D-incompatible apheresis PLT transfusion.

RESULTS: A total of 158 of 1107 apheresis PLT recipients were D-. Seventy-nine were eligible for analysis based on the exclusion criteria listed above. None became alloimmunized to D during the observation interval. In 45 (57%) cases the last follow-up antibody screen was obtained at least 4 weeks after the first D-incompatible apheresis PLT transfusion.

CONCLUSION: Prospective surveillance confirms prior retrospective observations that D- patients do not appear to risk D alloimmunization after receiving D+ apheresis PLTs.

Rights and Permissions

Citation: Transfusion. 2015 Jun;55(6):1327-30. doi: 10.1111/trf.12972. Epub 2014 Dec 19. Link to article on publisher's site. Epub 2014 Dec 19.

Related Resources

Link to Article in PubMed

PubMed ID

25523100